Article info
PDFOriginal research
Predicting oncotype DX recurrence scores using locally available immunohistochemical markers: experience in a district general hospital
- Correspondence to Dr John Stephenson, Allied Health Sciences, Sport & Exercise, University of Huddersfield, Huddersfield, Kirklees, UK; J.Stephenson{at}hud.ac.uk
Citation
Predicting oncotype DX recurrence scores using locally available immunohistochemical markers: experience in a district general hospital
Publication history
- Received September 15, 2021
- Accepted November 9, 2021
- First published December 13, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (17 March 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.